The oversuppression syndrome.
D000236:Adenoma / Q000175:diagnosis; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000494:pharmacology; D003348:Cortisone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D007247:Infertility, Female / Q000139:chemically induced; D008599:Menstruation Disturbances / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000175:diagnosis; D011372:Progestins / Q000494:pharmacology
D006063:Chorionic Gonadotropin; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D002996:Clomiphene; D005640:Follicle Stimulating Hormone; D003348:Cortisone